
DaVita Inc.
- Jurisdiction
United States - LEI
M2XHYMU3TZNEZURC6H66 - ISIN
US23918K1088 (DVA )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
6
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
6
/ 7
Profile
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. Read full profile
Stock price
Fundamentals
- Net revenue
€11.29B - Gross margin
31.2% - EBIT
€1.78B - EBIT margin
15.7% - Net income
€717.52M - Net margin
6.4%
Statement period: - (published )
Dividends
No dividend payouts
Congress transactions
Name | Transaction date | Value |
---|---|---|
Julie Johnson | October 7, 2025 | $1.00K–$15.00K |
Earnings Calls
Latest earnings call: August 5, 2025
Investor transactions
Name | Shares | Value | Last change | Change type |
---|---|---|---|---|
Warren Buffett |
|
|
|
Sell |
Ray Dalio |
|
|
|
Sell |